mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00091 |
1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00096 |
1 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.00087 |
1 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00075 |
1 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.00065 |
1 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.00071 |
1 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.00072 |
1 |